
Vitamin D's emerging links to diabetes risk, brain biomarkers, and gut immunity
New studies suggest vitamin D may influence several chronic diseases: high-dose vitamin D (4,000 IU/day) reduced progression from prediabetes to type 2 diabetes in people with AC/CC variants of the vitamin D receptor gene, but had no benefit for others and excess doses carry risks; higher vitamin D levels in midlife were linked to lower tau protein, a biomarker for Alzheimer's, years later but not with beta-amyloid and the study had limitations; in inflammatory bowel disease, 12 weeks of vitamin D supplementation reduced gut inflammation and promoted a more balanced immune response (increasing IgA, decreasing IgG), indicating potential as an adjunct therapy. Overall, vitamin D is not a cure-all and results are preliminary, needing replication and careful medical supervision.







